Skip to main content

Table 1

From: O223 Antiretroviral Pregnancy Registry (APR) at 10,000 prospective reports

 

Defects

LB Prevalence (95%CI)

Zidovudine

87/2808

3.1% (2.5%,3.8%)

Lamivudine

85/2784

3.1% (2.4%,3.8%)

Nelfinavir

33/972

3.4% (2.3%,4.7%)

Nevirapine

18/737

2.4% (1.5%,3.8%)

Stavudine

19/651

2.9% (1.8%,4.5%)

Ritonavir

16/628

2.5% (1.5%,4.1%)

Abacavir

17/512

3.3% (1.9%,5.3%)

Tenofovir

11/491

2.2% (1.1%,4.0%)

Efavirenz

10/364

2.7% (1.3%,5.0%)

Didanosine

16/353

4.5% (2.6%,7.3%)

Lopinavir

6/328

1.8% (0.7%,3.9%)

Indinavir

6/272

2.2% (0.8%,4.7%)